Non-cancerous tumours and conditions of the biliary tract

Last medical review:

A non-cancerous (benign) tumour of the biliary tract is a growth that does not spread (metastasize) to other parts of the body. Non-cancerous tumours are not usually life-threatening. They are typically removed with surgery and do not usually come back (recur).

A non-cancerous (benign) condition of the biliary tract is a change in the gallbladder or bile duct, but it is not cancer. Non-cancerous conditions do not spread (metastasize) to other parts of the body and are not usually life-threatening.

There are many types of non-cancerous tumours and conditions of the biliary tract.

Gallstones

Gallstones are the most common non-cancerous condition of the biliary tract. They are formed inside the gallbladder when the substances that make up bile harden. If the gallstones leave the gallbladder and enter the bile ducts, they can block the flow of bile and cause symptoms like abdominal pain and jaundice. Gallstones are usually treated with surgery to remove the gallbladder (cholecystectomy).

About 10% to 20% of Canadians will have gallstones at some point in their life, though only about 10% to 20% of these people have symptoms. In Canada, gallstones occur more frequently in women than men and in Indigenous peoples than other ethnicities. They are also more common in older people and those with a high body mass index (BMI).

Primary biliary cholangitis

Primary biliary cholangitis is caused by autoimmune destruction of the intrahepatic bile ducts. As the condition worsens, it causes liver cirrhosis that stops the liver and bile ducts from working properly.

Gallbladder adenomyomatosis

Gallbladder adenomyomatosis is caused by rapid growth of gallbladder walls. This condition causes the walls of the gallbladder to thicken and small empty pockets (called Rokitansky-Aschoff sinuses) to form from the walls lining the inside of the gallbladder.

Other non-cancerous tumours

Rare non-cancerous tumours of the biliary tract include:

  • bile duct adenomas
  • bile duct hamartomas
  • choledochal cysts

Expert review and references

  • Vincent Tam, BSc(Hon), MD, FRCPC
  • Chen L, Xu MY, Chen F. Bile duct adenoma: a case report and literature review. World Journal of Surgical Oncology. 2014: 12:125.
  • DiGiacinto J, Macon BL. A Guide to Gallstones. Healthline; 2023. https://www.healthline.com/.
  • Golse N, Lewin M, Rode A, Sebagh M, Mabrut JY. Gallbladder adenomyomatosis: Diagnosis and management. Journal of Visceral Surgery. 2017: 154(5):345–353.
  • Mayo Clinic. Primary biliary cholangitis. 2023. https://www.mayoclinic.org.
  • Mejri A, Arfaoui K, Omri A, Rchidi J, Mseddi MA, Saad S. Gallbladder adenomyomatosis: Diagnosis and management. International Journal of Surgery Case Reports. 2021: 84:106089.
  • NHS Website Content. Gallstones. 2021. https://www.nhs.uk/.
  • Saiman Y. Gallstones. Merck Manual Consumer Version. Kenilworth, NJ: Merck & Co, Inc; 2023. https://www.merckmanuals.com/en-ca/home.
  • Sheikh AAE, Nguyen AP, Leyba K, Javed N, Shah S, Deradke A, et al.. Bile duct hamartomas: A systematic review. Cureus. 2022: 14(5): e25361.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2024 Canadian Cancer Society